The global remote patient monitoring (RPM) market is estimated to be valued at $40 Billion in 2023, and is expected to grow ...

The U.S. Food and Drug Administration is urging all patients with smartphone-compatible diabetes devices to check the ...

People with type 1 diabetes require continuous insulin treatment and must regularly measure their glucose levels. With ...

A U.K. court has ruled against Abbott in a trademark infringement case the company had brought over the design of a rival ...

The FDA has issued a safety communication regarding the potential for missed alerts with diabetes devices due to software or hardware changes.

For people living with Type 1 Diabetes (T1D), keeping blood sugar levels in check is a constant challenge. A new clinical trial at UVA is aiming to simplify diabetes management by testing an ...

The global Diabetes Drugs Market size was valued at USD 84.65 billion in 2024 and is expected to be worth around USD 177.74 ...

Groundbreaking research exposes how diabetes damages kidneys, offering hope through early detection and innovative prevention ...

The DVLA must be told of any medical conditions that could affect your driving - and failing to inform them could result in a ...

The Biosensors Market is growing with demand for rapid, accurate diagnostics in healthcare, food safety, and environmental monitoring, driven by advances in biotechnology.Austin, Feb. 12, 2025 (GLOBE ...

Motorists could be slapped with fines of up to £1,000 if they fail to tell the DVLA about certain health conditions that ...

We recently published a list of the 10 Best Medical Device Stocks To Buy According to Hedge Funds. In this article, we are ...